We serve Chemical Name:2-phenylethyl 3-methylbut-2-enoate CAS:42078-65-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-phenylethyl 3-methylbut-2-enoate
CAS.NO:42078-65-9
Synonyms:2-Butenoic acid,3-methyl-,2-phenylethyl ester;Phenethyl 3,3-dimethylacrylate;Phenethyl senecioate;Phenethyl 3-methylcrotonate;2-Phenylethyl 3-methyl-2-butenoate;2-Phenylethyl senecioate;FEMA No. 2869;EINECS 255-649-4;Phenethyl 3-methylbut-2-enoate
Molecular Formula:C13H16O2
Molecular Weight:204.26500
HS Code:2916190090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:306.3ºC at 760 mmHg
Density:1.012 g/cm3
Index of Refraction:1.513
PSA:26.30000
Exact Mass:204.11500
LogP:2.73850
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Butenoic acid,3-methyl-,2-phenylethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenethyl 3-methylbut-2-enoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 255-649-4 Use and application,2-Butenoic acid,3-methyl-,2-phenylethyl ester technical grade,usp/ep/jp grade.
Related News: Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. 2-bromomethyl-5-bromo-4-phenyl oxazole manufacturers EMA’s human medicines committee (CHMP) has endorsed findings of a review which concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML). 4-((5-bromo-4-((3,4-difluorophenyl)amino)pyrimidin-2-yl)amino)benzoic acid hydrochloride suppliers Mindset’s Family 1 compounds leverage state-of-the art modern drug design using conjugated and deuterated psilocybin and psilocin design strategies to improve on psilocybin’s potential toxicity and pharmacokinetic profiles. trans-dihydroxo(2,3,6,7,12,13,16,17-octaethylporphyrinato)tin(IV) vendor & factory.
